Compare Exelixis Inc. Common Stock (EXEL) vs Expensify Inc (EXFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Expensify Inc — how do they compare? Exelixis Inc. Common Stock trades at $59.11 (market cap $14.62B), while Expensify Inc trades at $2.3 (market cap $208.82M). The key difference: Exelixis Inc. Common Stock is far larger — about 70× Expensify Inc's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Expensify Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Expensify Inc for 41 Days on average.
| EXEL | EXFY | |
|---|---|---|
Market Cap | $14.62B | $208.82M |
Volume | 2,684,957 | 456,102 |
Sector | Health | Technology |
52-Week High | $59.13 | $2.72 |
52-Week Low | $34.54 | $0.75 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $13.95B | $148.44M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Expensify (EXFY) trades at $2.27, up 1.79% with a neutral technical signal. The company shows mixed fundamentals with revenue stabilizing around $140M but persistent net losses. Recent quarters show earnings improvement with two beats, while analyst consensus is bullish with a $13.75 price target. Business developments include AI integrations and European expansion of corporate card offerings.
The outlook remains speculative given negative profitability metrics, though cash flow improvements and strategic partnerships provide potential catalysts. Key risks include competitive pressure in expense management and the challenge of achieving sustainable profitability. The significant gap between current price and analyst targets suggests upside potential if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →
